TBPH 8-K 2026-08-10

Theravance Biopharma, Inc. (TBPH) 8-K dated 2026-08-10 — accession 0001104659-26-093066. This URL is the filing, not the TBPH hub.

Theravance Biopharma, Inc. (TBPH) is a biotechnology company listed on NASDAQ.

Theravance Biopharma, Inc. filed a 8-K on 2026-08-10. Accession 0001104659-26-093066.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.

Not investment advice. The TBPH SEC hub lists recent forms. The stock page is the research view.